Related references
Note: Only part of the references are listed.Novel preparation of bilirubin-encapsulated pluronic F-127 nanoparticles as a potential biomaterial for wound healing
Dhaval J. Kamothi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2022)
Bilirubin as a Therapeutic Molecule: Challenges and Opportunities
Christopher A. Adin
ANTIOXIDANTS (2021)
Bilirubin: A Promising Therapy for Parkinson's Disease
Sri Jayanti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Bilirubin: The yellow hormone?
Libor Vitek et al.
JOURNAL OF HEPATOLOGY (2021)
Polymorphisms of Interleukin-6 and Interleukin-8 Are Not Associated with Parkinson's Disease in Taiwan
Tsai-Wei Liu et al.
BRAIN SCIENCES (2021)
Parkinson disease
R. Balestrino et al.
EUROPEAN JOURNAL OF NEUROLOGY (2020)
CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson's disease: a study in LRRK2 mutation carriers
Nour K. Majbour et al.
TRANSLATIONAL NEURODEGENERATION (2020)
Parkinson's disease: etiopathogenesis and treatment
Joseph Jankovic et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)
2-Hydroxy-4-Methylbenzoic Anhydride Inhibits Neuroinflammation in Cellular and Experimental Animal Models of Parkinson's Disease
Soo-Yeol Song et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Earliest Mechanisms of Dopaminergic Neurons Sufferance in a Novel Slow Progressing Ex Vivo Model of Parkinson Disease in Rat Organotypic Cultures of Substantia Nigra
Matteo Dal Ben et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
N-Acetyl Cysteine Is Associated With Dopaminergic Improvement in Parkinson's Disease
Daniel A. Monti et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
D-T7 Peptide-Modified PEGylated Bilirubin Nanoparticles Loaded with Cediranib and Paclitaxel for Antiangiogenesis and Chemotherapy of Glioma
Meinan Yu et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Increased serum levels of TNF-alpha and decreased serum levels of IL-27 in patients with Parkinson disease and their correlation with disease severity
Ebrahim Kouchaki et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2018)
Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease
Emily M. Rocha et al.
NEUROBIOLOGY OF DISEASE (2018)
Discovering New Benefits From Old Drugs With Big Data-Promise for Parkinson Disease
Abby L. Olsen et al.
JAMA NEUROLOGY (2018)
Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease
Inga Peter et al.
JAMA NEUROLOGY (2018)
The Parkinson Pandemic-A Call to Action
E. Ray Dorsey et al.
JAMA NEUROLOGY (2018)
On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease
Nicolas Giguere et al.
FRONTIERS IN NEUROLOGY (2018)
Nonsteroidal anti-inflammatory drugs use and risk of Parkinson disease A dose-response meta-analysis
Li Ren et al.
MEDICINE (2018)
Histone acetylation as a new mechanism for bilirubin-induced encephalopathy in the Gunn rat
Eleonora Vianello et al.
SCIENTIFIC REPORTS (2018)
Epidemiology of Parkinson's disease
Ole-Bjorn Tysnes et al.
JOURNAL OF NEURAL TRANSMISSION (2017)
N-Acetyl-L-Cysteine Protects Astrocytes against Proteotoxicity without Recourse to Glutathione
Amanda M. Gleixner et al.
MOLECULAR PHARMACOLOGY (2017)
Neurochemistry International Evaluation of the rotenone-induced activation of the Nrf2 pathway in a neuronal model derived from human induced pluripotent stem cells
Dimitra Zagoura et al.
NEUROCHEMISTRY INTERNATIONAL (2017)
Relationship of circulatory BDNF with cognitive deficits in people with Parkinson's disease
Hanan Khalil et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
IL-6 serum levels are elevated in Parkinson's disease patients with fatigue compared to patients without fatigue
Jessica Ramos Pereira et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD)
Caroline H. Williams-Gray et al.
MOVEMENT DISORDERS (2016)
A Novel Perspective on the Biology of Bilirubin in Health and Disease
Silvia Gazzin et al.
TRENDS IN MOLECULAR MEDICINE (2016)
N-Acetyl Cysteine May Support Dopamine Neurons in Parkinson's Disease: Preliminary Clinical and Cell Line Data
Daniel A. Monti et al.
PLOS ONE (2016)
Looking to the horizon: the role of bilirubin in the development and prevention of age-related chronic diseases
Karl-Heinz Wagner et al.
CLINICAL SCIENCE (2015)
Increased bilirubin levels in de novo Parkinson's disease
M. Moccia et al.
EUROPEAN JOURNAL OF NEUROLOGY (2015)
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma et al.
MOVEMENT DISORDERS (2015)
Neurotensin-polyplex-mediated brain-derived neurotrophic factor gene delivery into nigral dopamine neurons prevents nigrostriatal degeneration in a rat model of early Parkinson's disease
Nancy G. Hernandez-Chan et al.
JOURNAL OF BIOMEDICAL SCIENCE (2015)
Blood-Brain Barrier and Bilirubin: Clinical Aspects and Experimental Data
Maria Alexandra Brito et al.
ARCHIVES OF MEDICAL RESEARCH (2014)
Bilirubin mediated oxidative stress involves antioxidant response activation via Nrf2 pathway
Mohammed Qaisiya et al.
CELLULAR SIGNALLING (2014)
Association Between Serum Concentration of Infliximab and Efficacy in Adult Patients With Ulcerative Colitis
Omoniyi J. Adedokun et al.
GASTROENTEROLOGY (2014)
Vulnerability of the Mesencephalic Dopaminergic Neurons of the Human Neonate to Prolonged Perinatal Hypoxia: An Immunohistochemical Study of Tyrosine Hydroxylase Expression in Autopsy Material
Marianna A. Pagida et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2013)
Hyperbilirubinemia, Augmentation of Endothelial Function, and Decrease in Oxidative Stress in Gilbert Syndrome
Tatsuya Maruhashi et al.
CIRCULATION (2012)
Rotenone, Paraquat, and Parkinson's Disease
Caroline M. Tanner et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2011)
Serum heme oxygenase-1 levels are increased in Parkinson's disease but not in Alzheimer's disease
I. Mateo et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Tumor necrosis factor-alpha mediated signaling in neuronal homeostasis and dysfunction
Keigan M. Park et al.
CELLULAR SIGNALLING (2010)
Chronic expression of low levels of tumor necrosis factor-α in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia/macrophage activation
Ana Laura De Lella Ezcurra et al.
NEUROBIOLOGY OF DISEASE (2010)
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
Stephen A. Bustin et al.
CLINICAL CHEMISTRY (2009)
NSAID Use and the Risk of Parkinson's Disease Systematic Review and Meta-Analysis of Observational Studies
Ali Samii et al.
DRUGS & AGING (2009)
Bilirubin possesses powerful immunomodulatory activity and suppresses experimental autoimmune encephalomyelitis
Yingru Liu et al.
JOURNAL OF IMMUNOLOGY (2008)
Overexpression of Heme Oxygenase-1 Protects Dopaminergic Neurons against 1-Methyl-4-Phenylpyridinium-Induced Neurotoxicity
Shih-Ya Hung et al.
MOLECULAR PHARMACOLOGY (2008)
Pharmacologic induction of heme oxygenase-1
Cheng Li et al.
ANTIOXIDANTS & REDOX SIGNALING (2007)
Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention
Malu G. Tansey et al.
EXPERIMENTAL NEUROLOGY (2007)
Dopamine induces TNFα and TNF-R1 expression in SH-SY5Y human neuroblastoma cells
Cristina Gomez-Santos et al.
NEUROREPORT (2007)
Factors affecting the binding of bilirubin to serum albumins: Validation and application of the peroxidase method
Leslye Roca et al.
PEDIATRIC RESEARCH (2006)
Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease
Melissa K. McCoy et al.
JOURNAL OF NEUROSCIENCE (2006)
Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures
CM Testa et al.
MOLECULAR BRAIN RESEARCH (2005)
Bilirubin benefits: Cellular protection by a biliverdin reductase antioxidant cycle
TW Sedlak et al.
PEDIATRICS (2004)
Reassessment of the unbound concentrations of unconjugated bilirubin in relation to neurotoxicity in vitro
JD Ostrow et al.
PEDIATRIC RESEARCH (2003)
Bilirubin as a potent antioxidant suppresses experimental autoimmune encephalomyelitis: implications for the role of oxidative stress in the development of multiple sclerosis
YR Liu et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Biliverdin reductase:: A major physiologic cytoprotectant
DE Barañano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Tumor necrosis factor α is toxic to embryonic mesencephalic dopamine neurons
SO McGuire et al.
EXPERIMENTAL NEUROLOGY (2001)
Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from Parkinsonian brain
M Mogi et al.
JOURNAL OF NEURAL TRANSMISSION (2000)
Share Paper
